Albers GW - Search Results

1

Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis.

Singer OC, Berkefeld J, Lorenz MW, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T; MR Stroke Study Group Investigators. Singer OC, et al. Among authors: albers gw. Cerebrovasc Dis. 2009;27(4):368-74. doi: 10.1159/000202427. Epub 2009 Feb 16. Cerebrovasc Dis. 2009. PMID: 19218803 Free PMC article.

2

Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke.

Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Tong DC, et al. Among authors: albers gw. Neurology. 1998 Apr;50(4):864-70. doi: 10.1212/wnl.50.4.864. Neurology. 1998. PMID: 9566364

3

MRI abnormalities associated with partial status epilepticus.

Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. Lansberg MG, et al. Among authors: albers gw. Neurology. 1999 Mar 23;52(5):1021-7. doi: 10.1212/wnl.52.5.1021. Neurology. 1999. PMID: 10102423

4

Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI.

Marks MP, Tong DC, Beaulieu C, Albers GW, de Crespigny A, Moseley ME. Marks MP, et al. Among authors: albers gw. Neurology. 1999 Jun 10;52(9):1792-8. doi: 10.1212/wnl.52.9.1792. Neurology. 1999. PMID: 10371525

5

A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage.

Tong DC, Albers GW, Yenari MA, Marks MP. Tong DC, et al. Among authors: albers gw. Stroke. 1999 Sep;30(9):1974-5. doi: 10.1161/01.str.30.9.1974a. Stroke. 1999. PMID: 10471453 No abstract available.

6

Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome.

Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP. Beaulieu C, et al. Among authors: albers gw. Ann Neurol. 1999 Oct;46(4):568-78. doi: 10.1002/1531-8249(199910)46:4<568::aid-ana4>3.0.co;2-r. Ann Neurol. 1999. PMID: 10514093

7

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Clark WM, et al. Among authors: albers gw. JAMA. 1999 Dec 1;282(21):2019-26. doi: 10.1001/jama.282.21.2019. JAMA. 1999. PMID: 10591384 Clinical Trial.

8

Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist.

Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, Norris J. Davis SM, et al. Among authors: albers gw. Stroke. 2000 Feb;31(2):347-54. doi: 10.1161/01.str.31.2.347. Stroke. 2000. PMID: 10657404 Clinical Trial.

9

Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Albers GW, et al. JAMA. 2000 Mar 1;283(9):1145-50. doi: 10.1001/jama.283.9.1145. JAMA. 2000. PMID: 10703776 Clinical Trial.

10

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.

Clark WM, Albers GW, Madden KP, Hamilton S. Clark WM, et al. Among authors: albers gw. Stroke. 2000 Apr;31(4):811-6. doi: 10.1161/01.str.31.4.811. Stroke. 2000. PMID: 10753980 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

584 results

Search Page